Good morning :)
Place Order
Add to Watchlist

Gujarat Terce Laboratories Ltd

GUJTERC Share Price

49.541.78% (-0.90)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹37 cr, stock is ranked 3,836

High Risk

Stock is 4.33x as volatile as Nifty

GUJTERC Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹37 cr, stock is ranked 3,836

High Risk

Stock is 4.33x as volatile as Nifty

GUJTERC Performance & Key Metrics

GUJTERC Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-38.595.26—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
37.086.540.76%

GUJTERC Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

GUJTERC Company Profile

Gujarat Terce Laboratories is engaged in manufacturing of tablets, capsules, and syrup and injection pertaining to the product group pharmaceuticals.

GUJTERC Similar Stocks (Peers)

Compare with peers Compare with peers 

GUJTERC Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
37.40
37.40
1Y Return
6.23%
6.23%
Buy Reco %
84.85
84.85
Cipla Ltd
CIPLA
PE Ratio
22.71
22.71
1Y Return
1.62%
1.62%
Buy Reco %
68.75
68.75
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
62.06
62.06
1Y Return
15.14%
15.14%
Buy Reco %
70.83
70.83
Mankind Pharma Ltd
MANKIND
PE Ratio
54.71
54.71
1Y Return
24.01%
24.01%
Buy Reco %
81.25
81.25
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
18.59
18.59
1Y Return
5.70%
5.70%
Buy Reco %
48.39
48.39
Compare with Peers

GUJTERC Forecast

GUJTERC Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

GUJTERC

GUJTERC

Income

Balance Sheet

Cash Flow

GUJTERC Income Statement

GUJTERC Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 5.95%, vs industry avg of 10.46%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.02% to 0.01%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue25.7329.4231.3537.8325.9840.4447.1348.2950.5050.50
Raw Materialssubtract9.3711.0311.8414.2810.2517.8817.7016.6546.3146.31
Power & Fuel Costsubtract0.050.060.080.100.100.160.110.17
Employee Costsubtract10.6411.9312.8214.8112.6315.4914.3815.11
Selling & Administrative Expensessubtract3.573.823.856.023.935.9714.5713.44
Operating & Other expensessubtract1.581.851.961.661.03-0.482.181.34
Depreciation/Amortizationsubtract0.190.190.210.240.180.280.360.370.380.38
Interest & Other Itemssubtract0.310.230.250.290.390.400.720.680.420.41
Taxes & Other Itemssubtract0.030.05-0.090.16-0.01-0.13-1.220.304.374.37
EPS-0.010.350.580.36-3.401.17-2.250.31-1.31-1.31
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00
See Costs

GUJTERC Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Feb 5PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

May 13PDF
May 13PDF
FY 2022FY 2022

Annual report

PDF

Investor Presentation

Oct 28PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

GUJTERC Stock Peers

GUJTERC Past Performance & Peer Comparison

GUJTERC Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation-basic on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Gujarat Terce Laboratories Ltd-38.195.26—
Sun Pharmaceutical Industries Ltd37.405.640.94%
Cipla Ltd22.713.831.08%
Torrent Pharmaceuticals Ltd62.0615.630.91%

GUJTERC Stock Price Comparison

Compare GUJTERC with any stock or ETF
Compare GUJTERC with any stock or ETF
GUJTERC
Loading...

GUJTERC Holdings

GUJTERC Shareholdings

GUJTERC Promoter Holdings Trend

GUJTERC Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

GUJTERC Institutional Holdings Trend

GUJTERC Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

GUJTERC Shareholding Pattern

GUJTERC Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding37.03%0.00%0.00%0.00%62.97%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

GUJTERC Shareholding History

GUJTERC Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

GUJTERC Insider Trades & Bulk Stock Deals

GUJTERC Insider Trades & Bulk Stock Deals

Loading...

smallcases containing GUJTERC stock

smallcases containing GUJTERC stock

Looks like this stock is not in any smallcase yet.

GUJTERC Events

GUJTERC Events

GUJTERC Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

GUJTERC has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

GUJTERC Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

GUJTERC has not given any dividends in last 5 years

GUJTERC Dividends

GUJTERC Dividends

Hmm, looks like data is unavailable here. Please come back after some time

GUJTERC Stock News & Opinions

GUJTERC Stock News & Opinions

Corporate
Gujarat Terce Laboratories to convene AGM

Gujarat Terce Laboratories announced that the Annual General Meeting(AGM) of the company will be held on 21 August 2025.Powered by Capital Market - Live

1 day agoCapital Market - Live
Corporate
Gujarat Terce Laboratories schedules board meeting

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 17 July 2025.Powered by Capital Market - Live

1 week agoCapital Market - Live
Earnings
Gujarat Terce Laboratories reports standalone net loss of Rs 3.39 crore in the March 2025 quarter

Net loss of Gujarat Terce Laboratories reported to Rs 3.39 crore in the quarter ended March 2025 as against net profit of Rs 0.54 crore during the previous quarter ended March 2024. Sales rose 0.90% to Rs 12.32 crore in the quarter ended March 2025 as against Rs 12.21 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 0.98 crore in the year ended March 2025 as against net profit of Rs 0.24 crore during the previous year ended March 2024. Sales rose 4.65% to Rs 50.20 crore in the year ended March 2025 as against Rs 47.97 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales12.3212.21 1 50.2047.97 5 OPM %8.528.19 -7.732.65 - PBDT1.070.93 15 3.770.91 314 PBT0.970.84 15 3.390.54 528 NP-3.390.54 PL -0.980.24 PL Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Gujarat Terce Laboratories to discuss results

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 26 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Gujarat Terce Laboratories standalone net profit rises 50.75% in the December 2024 quarter

Net profit of Gujarat Terce Laboratories rose 50.75% to Rs 1.01 crore in the quarter ended December 2024 as against Rs 0.67 crore during the previous quarter ended December 2023. Sales declined 2.61% to Rs 12.68 crore in the quarter ended December 2024 as against Rs 13.02 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales12.6813.02 -3 OPM %8.606.45 - PBDT1.080.76 42 PBT0.980.67 46 NP1.010.67 51 Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Gujarat Terce Laboratories schedules board meeting

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 4 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Gujarat Terce Laboratories standalone net profit rises 348.48% in the September 2024 quarter

Net profit of Gujarat Terce Laboratories rose 348.48% to Rs 1.48 crore in the quarter ended September 2024 as against Rs 0.33 crore during the previous quarter ended September 2023. Sales rose 10.56% to Rs 13.30 crore in the quarter ended September 2024 as against Rs 12.03 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales13.3012.03 11 OPM %12.414.49 - PBDT1.600.42 281 PBT1.510.33 358 NP1.480.33 348 Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Gujarat Terce Laboratories to declare Quarterly Result

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 28 October 2024.Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Gujarat Terce Laboratories to convene AGM

Gujarat Terce Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 17 September 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live
Earnings
Gujarat Terce Laboratories reports standalone net loss of Rs 0.08 crore in the June 2024 quarter

Net Loss of Gujarat Terce Laboratories reported to Rs 0.08 crore in the quarter ended June 2024 as against net loss of Rs 1.31 crore during the previous quarter ended June 2023. Sales rose 10.91% to Rs 11.89 crore in the quarter ended June 2024 as against Rs 10.72 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales11.8910.72 11 OPM %0.67-10.54 - PBDT0.02-1.22 LP PBT-0.07-1.31 95 NP-0.08-1.31 94 Powered by Capital Market - Live

11 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Gujarat Terce Laboratories Ltd (GUJTERC) today?

    The share price of GUJTERC as on 18th July 2025 is ₹49.54. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Gujarat Terce Laboratories Ltd (GUJTERC) share?

    The past returns of Gujarat Terce Laboratories Ltd (GUJTERC) share are
    • Past 1 week: 4.00%
    • Past 1 month: -14.94%
    • Past 3 months: -15.54%
    • Past 6 months: -33.60%
    • Past 1 year: 2.34%
    • Past 3 years: 60.71%
    • Past 5 years: 528.17%

  3. What are the peers or stocks similar to Gujarat Terce Laboratories Ltd (GUJTERC)?

    The peers or stocks similar to Gujarat Terce Laboratories Ltd (GUJTERC) include:

  4. What is the market cap of Gujarat Terce Laboratories Ltd (GUJTERC) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Gujarat Terce Laboratories Ltd (GUJTERC) is ₹37.43 Cr as of 18th July 2025.

  5. What is the 52 week high and low of Gujarat Terce Laboratories Ltd (GUJTERC) share?

    The 52-week high of Gujarat Terce Laboratories Ltd (GUJTERC) is ₹94.90 and the 52-week low is ₹45.15.

  6. What is the PE and PB ratio of Gujarat Terce Laboratories Ltd (GUJTERC) stock?

    The P/E (price-to-earnings) ratio of Gujarat Terce Laboratories Ltd (GUJTERC) is -38.19. The P/B (price-to-book) ratio is 5.26.

  7. Which sector does Gujarat Terce Laboratories Ltd (GUJTERC) belong to?

    Gujarat Terce Laboratories Ltd (GUJTERC) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Gujarat Terce Laboratories Ltd (GUJTERC) shares?

    You can directly buy Gujarat Terce Laboratories Ltd (GUJTERC) shares on Tickertape. Simply sign up, connect your demat account and place your order.